About
Ashwin Nandakumar completed his DPhil in Oncology at the University of Oxford and conducted postdoctoral research in cancer biology at Oxford University and the Institute of Cancer Research in London. He has experience designing oncology clinical trials and working in early-stage oncology companies.
Ashwin Nandakumar, DPhil @menon_ashwin
Nature and its wonders!! https://t.co/tosrLZIjjw
Jun 3, 2026 Β· β₯ 3
Ashwin Nandakumar, DPhil @menon_ashwin
Excited to announce our $7.14M seed round at @GranzaBio led by @felicis and @refactor ! Weβre revolutionising the way we deliver therapeutic cargo to specific tissues - lots more to come! Read more at: https://t.co/3Jv3oTjUGg @ak_jainarayanan | @MichaelLDustin | @GranzaBio https://t.co/Imil5edxGK
Jul 3, 2024 Β· β₯ 49 Β· β 13
Ashwin Nandakumar, DPhil @menon_ashwin
Great article about our trial ππΎ A mountain of work from Val and everyone else involved ππΎ https://t.co/5g2G6HKm3u
Jun 18, 2023 Β· β₯ 9 Β· β 1
Founder at Granza BioYC W24
Intro paths
Ashwin went through Y Combinator (Winter 2024) β any YC alum in your network can reach them through the YC community.
Their group partner at YC was Jared Friedman, General Partner at Y Combinator β the partner who ran Granza Bio's batch and knows the company first-hand. YC profile β
In turn, Ashwin can intro founders to Granza Bio's investors below.
Granza Bio's investors Β· 7
Co-founders at Granza Bio
